What is JuneBrain?
JuneBrain Inc. operates at the intersection of ophthalmology and neurology, specializing in the development of portable Optical Coherence Tomography (OCT) devices integrated with advanced AI software. The company's core value proposition lies in its ability to facilitate remote monitoring of complex neurological and retinal conditions, effectively bridging the gap between clinical-grade diagnostics and point-of-care accessibility. By streamlining clinical trials and enhancing data collection for researchers, JuneBrain addresses critical inefficiencies in current healthcare delivery models.
As a women-owned small business, the company emphasizes diversity and technical excellence, positioning itself as a key player in the digital health ecosystem. Its technology is designed to empower clinicians with actionable insights, ultimately improving patient outcomes through more frequent and accessible monitoring of brain and eye health.
How much funding has JuneBrain raised?
JuneBrain has raised a total of $600K across 2 funding rounds:
Unspecified
$150K
Private Equity
$450K
Unspecified (2023): $150K with participation from TEDCO Business Support
Private Equity (2025): $450K, investors not publicly disclosed
Key Investors in JuneBrain
TEDCO Business Support
TEDCO is a business support organization that provides advisory services and entrepreneurial guidance to help startups secure capital and foster growth within their local business ecosystems.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for JuneBrain?
Looking ahead, the infusion of $450K provides the necessary runway for JuneBrain to scale its manufacturing capabilities and broaden its commercial footprint. The company is expected to prioritize the integration of its AI-driven analytics into broader telehealth networks, thereby increasing the utility of its OCT devices in diverse clinical environments. Strategic focus will likely shift toward securing regulatory milestones and expanding partnerships within the neurology and ophthalmology research communities.
Furthermore, the company is poised to leverage this capital to enhance its software-as-a-service (SaaS) offerings, ensuring that its diagnostic tools remain at the forefront of remote patient monitoring. As JuneBrain continues to mature, the focus will remain on scaling its operational infrastructure to meet the growing demand for decentralized healthcare solutions, ensuring that its portable technology becomes a standard component of modern neurological care.
